Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Gliatech and Abgenix enter XenoMouse technology collaboration

Jan. 20, 2000

Oxford BioMedica's LentiVector has potential application in cancer

Jan. 20, 2000

Phoenix and CuraGen enter transgenic research agreement

Jan. 20, 2000

AxyS announces combinatorial chemistry agreement with Searle

Jan. 19, 2000

Tripos and Parke-Davis to jointly develop high-throughput screening methods

Jan. 19, 2000

Xechem awarded SBIR grant for marine extremophile research

Jan. 19, 2000

Patent coverage granted for Cell Genesys's third-generation lentiviral vectors

Jan. 18, 2000

Protein Design Labs and Celltech Chiroscience enter antibody patent agreement

Jan. 18, 2000

Pharmacopeia achieves milestone in Schering collaboration

Jan. 18, 2000

Isis and AstraZeneca establish antisense target validation program

Jan. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.